Articles

Pharma companies are focusing on sustainability efforts to meet client expectations, environmental audits, and climate pressures.

Integrating Sustainability into the Core of Pharmaceutical Science

Christian Dowdeswell, managing director, Arcinova, a Quotient Sciences company, discusses what makes a CDMO that offers end-to-end service beneficial. 

Outsourcing Partners Providing End-to-End Service

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

Videos

The planned Kenvue acquisition, expected to close in the second half of 2026, has notable implications for pharmaceutical R&D and manufacturing professionals.

Kimberly-Clark to Buy Tylenol Maker Kenvue: Analyzing Risks and Rewards

Maggie Saykali reviews the key points of her CPHI Frankfurt presentation on the potential game-changing opportunities of the Critical Medicines Act.

How the Critical Medicines Act Aims to Optimize European Pharma Competitiveness and Resilience

J.D. Mowery, Bora, says global sustainability standards are good, AI implementation demands data cleansing, and outsourcing must mature.

Clearing Hurdles in Sustainability, AI, and CDMO Partnerships

Patient compliance is driving the emergence of new modalities, as Frank Romanski of Lonza Capsugel explains in the first installment of a two-part discussion.

Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One

Sriman Banerjee of Takeda Pharmaceuticals says patient adherence is improving thanks to technologies that offer a more personalized approach.

Takeda’s Sriman Banerjee Discusses Smart Packaging at CPHI Frankfurt 2025

J.D. Mowery discusses boosting pharma supply resilience through localized manufacturing, AI innovation, and critical regulatory standardization.

Standardizing Operations to Meet Global Sustainability and Resilience Goals

AI-driven pharma trends: R&D acceleration via data integration, supply chain localization, excipient innovation, and rapid workforce upskilling.

PharmTech Weekly News Roundup — Week of October 27, 2025

Feliza Mirasol is the science editor for 

In this episode of Drug Digest, the discussion centers around the optimization of biopharmaceutical manufacturing and supply chain efficiency through the mastering of AI capabilities, data integration, and critical validation challenges.